VRXA insider transaction filings
Veraxa Biotech AG - Post de-SPAC — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-31. Screen VRXA transaction legs live →
Insider transaction summary — last 90 days
2026-06-11 to 2026-09-09, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings by 2 insiders — 55,000 shares, $82,650 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 50,000 shares @ $1.50 ($75,000) by Baumann Oliver Rolf, filed 2026-08-31.
Recent Form 4 filings — Veraxa Biotech AG - Post de-SPAC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | Antz Christoph Rudiger — Chief Executive Officer, Director | Purchase (P): 5,000 @ $1.53 | EDGAR |
| 2026-08-31 | 4 | Baumann Oliver Rolf — Director | Purchase (P): 50,000 @ $1.50 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VRXA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →